An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent ΔE1-E2-E3-E4 Ad5 vectors

被引:21
|
作者
Catalucci, D [1 ]
Sporeno, E [1 ]
Cirillo, A [1 ]
Ciliberto, G [1 ]
Nicosia, A [1 ]
Colloca, S [1 ]
机构
[1] Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Roma, Italy
关键词
D O I
10.1128/JVI.79.10.6400-6409.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced immunogenicity to adenovirus gene products requires the concomitant generation of efficient packaging cell lines. High expression levels of the complementing genes must be achieved in a coordinated fashion with viral replication. This is a particularly difficult task in light of the significant cytotoxicity displayed by adenoviral proteins. To this end, we developed a novel adenovirus-based amplicon with an Epstein-Barr virus origin of replication, Ad type 5 (Ad5) inverted terminal repeats, all Ad5 early region 2 (E2) genes, and the early region 4 (E4) open reading frame 6 (ORF6) under the control of a tetracycline-dependent promoter. The amplicon (pE2) was stably maintained in multiple copies in the nuclei of 293 cells stably expressing the Epstein-Barr virus nuclear antigen 1 (EBNA1) and allowed replication as a linear DNA upon induction of E2 and ORF6 gene expression. A stable cell line (M) was generated by introducing pE2 into 293EBNATet cells expressing the tetracycline-dependent transcriptional silencer and the reverse Tet transactivator (rtTA2). Upon induction with doxicycline, 2E2 cells produced higher levels of polymerase, precursor terminal protein (pTP), and DNA binding protein than noninduced 2E2 cells infected with first-generation Ad5 vector and supported efficient amplification of a multiply deleted Ad5 vector lacking E1, E2, E3, and E4 genes (Ad5 Delta E1-4). The high cloning capacity of Ad5 Delta E1-4 (up to 12.6 kb) was exploited to construct a vector encoding the entire hepatitis C virus (HCV) polyprotein. Infection of HeLa cells by the resulting vector showed high levels of correctly processed HCV proteins.
引用
收藏
页码:6400 / 6409
页数:10
相关论文
共 50 条
  • [41] High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses
    Kron, Matthias W.
    Engler, Tatjana
    Schmidt, Erika
    Schirmbeck, Reinhold
    Kochanek, Stefan
    Kreppel, Florian
    JOURNAL OF GENE MEDICINE, 2011, 13 (12): : 648 - 657
  • [42] Short human TERT-promoter fragments as efficient tumor-specific transcriptional E1A-targets for anticancer gene therapy with (VP22)-Ad5/12E1A-derivatives
    Kirch, H
    Opalka, B
    Hengge, UR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 263 - 263
  • [43] The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Can Mimic E1A Effects on E2F
    Dallaire, Frederic
    Schreiner, Sabrina
    Blair, G. Eric
    Dobner, Thomas
    Branton, Philip E.
    Blanchette, Paola
    MSPHERE, 2016, 1 (01):
  • [44] Differential sensitivity to Ad5 E1B-21kD and bcl-2 proteins of apoptin-induced versus p53-induced apoptosis
    Zhuang, SM
    Shvarts, A
    Jochemsen, AG
    vanOorschot, AAAM
    vanderEb, A
    Noteborn, MHM
    CARCINOGENESIS, 1995, 16 (12) : 2939 - 2944
  • [45] The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Enhances E1A Functional Activity
    Dallaire, Frederic
    Schreiner, Sabrina
    Blair, G. Eric
    Dobner, Thomas
    Branton, Philip E.
    Blanchette, Paola
    MSPHERE, 2016, 1 (01):
  • [46] Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis
    Marcellus, RC
    Teodoro, JG
    Wu, T
    Brough, DE
    Ketner, G
    Shore, GC
    Branton, PE
    JOURNAL OF VIROLOGY, 1996, 70 (09) : 6207 - 6215
  • [47] Effect of the vaccine Ad5 [E1-, E2b-]-CEA(6D) on CEA-directed CMI responses in patients with advanced CEA-expressing malignancies in a phase I/II clinical trial
    Morse, Michael
    Hobeika, Amy
    Chaudhry, Arvind
    Amalfitano, Andrea
    Niedzwiecki, Donna
    Clay, Timothy M.
    Osada, Takuya
    Devi, Gayathri
    Burnett, Bruce K.
    Weinhold, Kent
    Hsu, Shiaowen David
    Blobe, Gerard C.
    Xu, Younong
    Nguyen, Susan
    Dua, Rajesh
    Balcaitis, Stephanie
    Gabitzsch, Elizabeth
    Balint, Joseph
    Jones, Frank
    Lyerly, H. Kim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein
    König, C
    Roth, J
    Dobbelstein, M
    JOURNAL OF VIROLOGY, 1999, 73 (03) : 2253 - 2262
  • [49] ADENOVIRUS TYPE-5 E3 GENE-PRODUCTS INTERFERE WITH THE EXPRESSION OF THE CYTOLYTIC T-CELL IMMUNODOMINANT E1A ANTIGEN
    ZHANG, XL
    BELLETT, AJD
    HLA, RT
    BRAITHWAITE, AW
    MULLBACHER, A
    VIROLOGY, 1991, 180 (01) : 199 - 206
  • [50] Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
    Joseph P. Balint
    Elizabeth S. Gabitzsch
    Adrian Rice
    Yvette Latchman
    Younong Xu
    Gerald L. Messerschmidt
    Arvind Chaudhry
    Michael A. Morse
    Frank R. Jones
    Cancer Immunology, Immunotherapy, 2015, 64 : 977 - 987